HealthyWay Inc.
2587.HK
Hong Kong Stock Exchange2.80
HKD
-0.11
- -
ISIN
KYG4412P1019
Return %
Stock
S&P500
1Y
-92.84
25.25
3Y
-73.73
70.54
5Y
-73.73
77.82
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Wanneng Zhang
- Full Time Employees
- 350
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Address
- No. 3 Building Fuzhou People's Republic of China 350000
- IPO Date
- Dec 30, 2024
- Website
- jkzlkj.cn
- Similar Companies
- Business
- HealthyWay Inc. operates as a digital health and medical service platform provider, focusing on a hybrid model that combines health services delivery with corporate digital marketing and IT services. The company engages in health and medical services, including health membership schemes, medical support services, value-based medical services, healthcare service packages, pharmaceutical sales, and related medical devices. It also operates a health platform and e-commerce/online/offline channels through which it markets health-related products and services to a broad range of customers, including individuals, hospitals, pharmaceutical companies, insurers, and local health authorities. The corporate services segment covers content services, information technology services, and digital marketing services that enable advertisers and partners to reach users on its platform and through third-party online media. Founding year and headquarters: HealthyWay Inc. is headquartered in Fuzhou, People’s Republic of China, and was founded in 2001. The company carries out most of its operations in the Chinese market, with reported corporate activity centered in health information services, digital marketing, and health-care platform offerings. Major corporate developments in recent years include expansion into AI-enabled healthcare offerings such as AI digital doctor assistants and AI health management tools, as well as corporate digital employees marketed to enterprise users; these initiatives have driven revenue diversification beyond traditional pharmaceutical sales and health service packages. Recent 1–2 year strategic moves include strengthening its health platform with AI-driven health services, pursuing partnerships and potential collaborations in health data services and digital health infrastructure, and adjusting its product mix toward scalable digital health solutions and corporate IT/digital marketing services to support platform growth. The company maintains subsidiaries and relationships aligned with its two primary segments: Health and Medical Services and Corporate and Digital Marketing Services, positioning HealthyWay as a dual-focused entity in both health services delivery and digital enablement for advertisers and corporate clients.